Cargando…

DC‐CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1‐ASK1‐AIP1 pathway to kill autologous ovarian cancer stem cells

Ovarian cancer stem cells (OCSCs) are highly carcinogenic and have very strong resistance to traditional chemotherapeutic drugs; therefore, they are an important factor in ovarian cancer metastasis and recurrence. It has been reported that dendritic cell (DC)‐cytokine‐induced killer (CIK) cells have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Wenxing, Xiong, Ying, Chen, Juan, Huang, Yongyi, Liu, Te
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010766/ https://www.ncbi.nlm.nih.gov/pubmed/29566310 http://dx.doi.org/10.1111/jcmm.13611

Ejemplares similares

Killing effects of Huaier Granule combined with DC-CIK on nude mice transplanted with colon carcinoma cell line
por: Sun, Wen-Wen, et al.
Publicado: (2017)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer
por: Liu, Chunyan, et al.
Publicado: (2019)

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy
por: Zhou, Yun, et al.
Publicado: (2018)

Menstrual and reproductive factors in relation to ovarian cancer risk
por: Titus-Ernstoff, L, et al.
Publicado: (2001)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019)

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
por: Song, Meng‐Jia, et al.
Publicado: (2021)

TOR1AIP1-Associated Nuclear Envelopathies
por: Mackels, Laurane, et al.
Publicado: (2023)

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
por: Zhang, Yajing, et al.
Publicado: (2013)

Comparative investigation of the effects of specific antigen-sensitized DC-CIK and DC-CTL cells against B16 melanoma tumor cells
por: Ren, Peng-Tao, et al.
Publicado: (2017)

Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer
por: Martínez-Reza, Isela, et al.
Publicado: (2017)

Case Report: Chemotherapy and Radiotherapy Combined With DC-CIK for Pulmonary and Mediastinal Metastases From Nasopharyngeal Carcinoma
por: Gan, Yi-Xiu, et al.
Publicado: (2022)

Combination treatment of pembrolizumab with DC-CIK cell therapy for advanced hepatocellular carcinoma: A case report
por: Huang, Shao M., et al.
Publicado: (2023)

Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible
por: Ma, Xiaoting, et al.
Publicado: (2023)

CSF-1-induced DC-SIGN(+) macrophages are present in the ovarian endometriosis
por: Xiaocui, Li, et al.
Publicado: (2022)

Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
por: Siegmund, Daniela, et al.
Publicado: (2016)

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
por: Wajant, Harald, et al.
Publicado: (2019)

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2023)

Prognostic and clinical significance of Solute Carrier Family 7 Member 1 in ovarian cancer
por: Gong, Wangang, et al.
Publicado: (2021)

Cordyceps militaris induces apoptosis in ovarian cancer cells through TNF-α/TNFR1-mediated inhibition of NF-κB phosphorylation
por: Jo, Eunbi, et al.
Publicado: (2020)

Innovative Clinical Perspectives for CIK Cells in Cancer Patients
por: Introna, Martino, et al.
Publicado: (2018)

Targeted killing of TNFR2-expressing tumor cells and T(regs) by TNFR2 antagonistic antibodies in advanced Sézary syndrome
por: Torrey, H, et al.
Publicado: (2018)

Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections
por: Ruiz, Andy, et al.
Publicado: (2021)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023)

Amyloid β Regulates the Expression and Function of AIP1
por: Wang, Huaiming, et al.
Publicado: (2014)

Enhanced Inhibitory Effect of DC-CIK Cells on Lung Adenocarcinoma via Anti-Tim-3 Antibody and Antiprogrammed Cell Death-1 Antibody and Possible Mechanism
por: Zhou, Liang, et al.
Publicado: (2022)

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2018)

DC-CIK biotherapy for a recurrent benign lymphoepithelial lesion of the salivary gland: A case report and literature review
por: XING, DEJUN, et al.
Publicado: (2014)

Comparative proteomic analysis of the mitochondria of menstrual stem cells and ovarian cancer cells
por: Chen, Xiuhui, et al.
Publicado: (2023)

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2023)

Effects of CIK on hypoxia inducible factor-1α and T-cell subsets on colon 26 cancer xenograft mice
por: ZHANG, HONGZHEN, et al.
Publicado: (2016)

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels
por: Nair, Deepika, et al.
Publicado: (2018)

Aip1p Interacts with Cofilin to Disassemble Actin Filaments
por: Rodal, Avital A., et al.
Publicado: (1999)

Gut region-specific TNFR expression: TNFR2 is more affected than TNFR1 in duodenal myenteric ganglia of diabetic rats
por: Barta, Bence Pál, et al.
Publicado: (2023)

Autologous cytokine‐induced killer (CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary study
por: Han, Ying, et al.
Publicado: (2020)

Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial
por: Sen, Taha, et al.
Publicado: (2021)

TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
por: Rauert, H, et al.
Publicado: (2011)

Cik1 and Vik1 accessory proteins confer distinct functions to the kinesin-14 Kar3
por: Bergman, Zane J., et al.
Publicado: (2023)

TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis
por: Shi, Gongping, et al.
Publicado: (2023)

The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response
por: Zafardoust, Simin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7n2uaimbr39k2iav28hgpp2rqd